Zynerba Pharmaceuticals, Inc. (ZYNE) Social Stream



Zynerba Pharmaceuticals, Inc. (ZYNE): $1.31

0.01 (+0.77%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Zynerba Pharmaceuticals Inc (ZYNE) Price Targets From Analysts

Use the tables below to see what analysts covering Zynerba Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-18 5 $9 $4.5 $7.35 $2.03 262.07%
2022-01-06 5 $9 $3.5 $7.15 $2.03 252.22%
2022-01-20 4 $9 $3.5 $6.625 $2.03 226.35%
2022-03-04 4 $9 $2.75 $6.437 $2.03 217.09%

The Trend in the Analyst Price Target


ZYNE's average price target has moved down $1.19 over the prior 43 weeks.

Over the past 47 weeks, ZYNE's average upside potential has been 91.78%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-08 4 9 4.5 7.630 4.49 69.93%
2021-08-14 4 9 4.5 7.630 4.09 86.55%
2021-09-11 4 9 4.5 7.630 4.47 70.69%
2021-11-15 5 9 4.5 7.350 4.30 70.93%
2022-01-20 4 9 3.5 6.625 2.38 178.36%

ZYNE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 3 0 1 0 0 4

The Trend in the Broker Recommendations


Over the past 59 days, ZYNE's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, Zynerba Pharmaceuticals Inc's average analyst price target is greater than 26.23% of them.
  • ZYNE has a greater upside potential (average analyst target price relative to current price) than 450.95% of all US stocks.
  • Zynerba Pharmaceuticals Inc's variance in analysts' estimates is lower than -325.37% of all US stocks.
  • To contextualize these metrics, consider that out of stocks in the micro market cap category, Zynerba Pharmaceuticals Inc's number of analysts covering the stock is greater than 403.12% of them.

Stocks similar to Zynerba Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ZSAN, XCUR, and VTVT.

Make investment decisions regarding ZYNE using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4329 seconds.